IL6 and Bartsocas-Papas syndrome 1: Most of them were strongly associated with inflammatory- and immune-related BPs such as “positive regulation of interleukin-6 biosynthetic process,” “regulation of inflammatory response,” “immune response,” and “positive regulation of T-cell proliferation.” In short, the 41 bioactive compounds in Quyushengxin formula may act on 94 candidate targets with inflammatory- and immune-related effects to affect UC pathogenesis.